Literature DB >> 32944906

Somatic Reprograming by Nuclear Transfer.

Vincent Brochard1, Nathalie Beaujean2,3.   

Abstract

Somatic cell nuclear transfer (SCNT) is a powerful technique, although challenging, to study reprograming into the totipotent state of differentiated nuclei in mammals. This procedure was initially applied in farm animals, then rodents, and more recently in primates. Nuclear transfer of embryonic stem cells is known to be more efficient, but many types of somatic cells have now been successfully reprogramed with this procedure. Moreover, SCNT reprograming is more effective on a per cell basis than induced Pluripotent Stem Cells (iPSC) and provides interesting clues regarding the underlying processes. In this chapter, we describe the protocol of nuclear transfer in mouse that combines cell cycle synchronization of the donor cells, enucleation of metaphase II oocyte and Piezo-driven injection of a donor cell nucleus followed by activation of the reconstructed embryos and nonsurgical transfer into pseudo-pregnant mice. Moreover, this protocol includes two facultative steps to erase the epigenetic "memory" of the donor cells and improve chromatin remodeling by histones modifications targeting.

Entities:  

Keywords:  HDACi; Mouse embryo; SCNT; Somatic cell nuclear transfer

Year:  2021        PMID: 32944906     DOI: 10.1007/978-1-0716-0958-3_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  PKC inhibitors regulate stem cell self-renewal by regulating H3K27me3 and H3K9me3.

Authors:  Jialei Sun; Na He; Weiguo Wang; Yujian Dai; Chunhui Hou; Fuliang Du
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Excavating the pathogenic gene of breast cancer based on high throughput data of tumor and somatic reprogramming.

Authors:  Lian Duan; Zhendong Wang; Xin Zheng; Junjian Li; Huamin Yin; Weibo Tang; Dejian Deng; Hui Liu; Jiayu Wei; Yan Jin; Feng Liu; Jingling Shen
Journal:  Cell Cycle       Date:  2021-08-13       Impact factor: 5.173

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.